Pernix Therapeutics Names John Sedor As Chairman and Interim CEO In Place Of Dough Drysdale

By: via Benzinga
Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical firm, appointed its Director, John Sedor, as its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.